Teri Dahlman
No más puestos en curso
Perfil
Teri Dahlman worked as an Investor Relations Contact at Tetraphase Pharmaceuticals, Inc.
Antiguos cargos conocidos de Teri Dahlman.
| Empresas | Cargo | Fin |
|---|---|---|
| TETRAPHASE PHARMACEUTICALS, INC. | Contacto de Relaciones con Inversores | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas privadas | 1 |
|---|---|
Tetraphase Pharmaceuticals, Inc.
 Tetraphase Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tetraphase Pharmaceuticals, Inc. is engaged in the development and production of novel tetracyclines for serious and life-threatening bacterial infections. It also develops eravacycline, a synthetic fluorocycline, as an intravenous and oral antibiotic for use as a first-line empiric monotherapy for the treatment of resistant and multi-drug-resistant infections. The company was founded on July 7, 2006 and is headquartered in Waltham, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Teri Dahlman
